ARTICLE | Company News
Texas Biotech asthma deal with Schering-Plough
July 10, 2000 7:00 AM UTC
TXB granted SGP exclusive worldwide development, manufacturing and marketing rights to its library of VLA-4 antagonists, which are in preclinical testing to treat asthma. SGP also received rights to a...